{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:24:15Z","timestamp":1759332255437},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.2169\/internalmedicine.2152-18","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:38:04Z","timestamp":1548974284000},"page":"1625-1627","source":"Crossref","is-referenced-by-count":3,"title":["Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (<i>EGFR<\/i>) Mutation with a History of Acquired Resistance to Osimertinib"],"prefix":"10.2169","volume":"58","author":[{"given":"Go","family":"Makimoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadoaki","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Senoo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Hotta","sequence":"additional","affiliation":[{"name":"Center of Innovative Clinical Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mok TS, Wu YL, Ahn MJ, et al. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med 376: 629-640, 2017.","DOI":"10.1056\/NEJMoa1612674"},{"key":"2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.lungcan.2009.06.025","volume":"68","author":"Y Tomizawa","year":"2010","unstructured":"2. Tomizawa Y, Fujita Y, Tamura A, et al. Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapy. Lung Cancer 68: 269-272, 2010.","journal-title":"Lung Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Thress KS, Paweletz CP, Felip E, et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nat Med 21: 560-562, 2015.","DOI":"10.1038\/nm.3854"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Le X, Puri S, Negrao MV, et al. Landscape of EGFR -dependent and -independent resistance mechanisms to osimertinib and continuation therapy post-progression in EGFR-mutant NSCLC. Clin Cancer Res 24: 6195-6203, 2018.","DOI":"10.1158\/1078-0432.CCR-18-1542"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oxnard GR, Hu Y, Mileham KF, et al. Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib. JAMA Oncol 4: 1527-1534, 2018.","DOI":"10.1001\/jamaoncol.2018.2969"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Asahina H, Oizumi S, Inoue A, et al. Phase II study of gefitinib readministration in patients with advanced non-small cell lung cancer and previous response to gefitinib. Oncology 79: 423-429, 2010.","DOI":"10.1159\/000326488"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Costa DB, Nguyen KS, Cho BC, et al. Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib. Clin Cancer Res 14: 7060-7067, 2008.","DOI":"10.1158\/1078-0432.CCR-08-1455"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chmielecki J, Foo J, Oxnard GR, et al. Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med 3: 90ra59, 2011.","DOI":"10.1126\/scitranslmed.3002356"},{"key":"9","unstructured":"9. Abbosh C, Birkbak NJ, Wilson GA, et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545: 446-451, 2017."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chaudhuri AA, Chabon JJ, Lovejoy AF, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov 7: 1394-1403, 2017.","DOI":"10.1158\/2159-8290.CD-17-0716"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/11\/58_2152-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:10:27Z","timestamp":1559362227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/11\/58_2152-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2152-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}